INS and diabetes mellitus: In our study, the percentage of pre-sarcopenia in diabetes with insulin sensitizers was lower than those with other anti-diabetic medication (15.85% vs. 18.86%, P = 0.499), yet there was no statistical difference because of the small sample size of insulin-sensitizers subgroup (n = 82).